Lymphoproliferative Disorders  >>  hydrocortisone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00002865: High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Completed
2
25
US
filgrastim, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, mesna, methotrexate, therapeutic hydrocortisone, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Leukemia
06/00
08/01
NCT00002785: Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia

Completed
2
US, Canada, RoW
filgrastim, asparaginase, cyclophosphamide, cyclosporine, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, leucovorin calcium, mercaptopurine, mesna, methotrexate, methylprednisolone, pegaspargase, prednisone, therapeutic hydrocortisone, vincristine sulfate, allogeneic bone marrow transplantation, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Children's Oncology Group, National Cancer Institute (NCI)
Leukemia
08/00
03/07
NCT00002552: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Completed
2
40
US
filgrastim, sargramostim, carmustine, cyclophosphamide, cytarabine, etoposide, leucovorin calcium, methotrexate, perfosfamide, therapeutic hydrocortisone, allogeneic bone marrow transplantation, autologous bone marrow transplantation, in vitro-treated bone marrow transplantation, peripheral blood stem cell transplantation, syngeneic bone marrow transplantation, radiation therapy
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
09/01
10/03
NCT00002494: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Completed
2
134
US
cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, mesna, methotrexate, prednisone, therapeutic hydrocortisone, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Leukemia, Lymphoma
03/04
01/06
NCT00002704: Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Completed
2
156
US, Canada, Europe
filgrastim, asparaginase, cyclophosphamide, daunorubicin hydrochloride, dexamethasone, etoposide, leucovorin calcium, liposomal cytarabine, mercaptopurine, mesna, methotrexate, therapeutic hydrocortisone, thiotepa, vincristine sulfate, low-LET electron therapy, low-LET photon therapy
National Cancer Institute (NCI)
Leukemia
06/04
 
NCT00176462: CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

Completed
2
60
US
aminopterin, L-asparaginase, cyclophosphamide, cytarabine, daunomycin, dexamethasone, 6-mercaptopurine, methotrexate, 6-thioguanine, vincristine, Triple Intrathecal Therapy (MTX, Cytarabine, Hydrocortisone), Leucovorin
Rutgers, The State University of New Jersey, National Cancer Institute (NCI)
Acute Lymphocytic Leukemia
09/08
09/08
NCT00618501: Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
2
50
RoW
cytarabine, daunorubicin hydrochloride, etoposide, imatinib mesylate, leucovorin calcium, methotrexate, prednisolone, therapeutic hydrocortisone, vincristine sulfate, allogeneic hematopoietic stem cell transplantation
Asan Medical Center
Leukemia
12/08
01/09
NCT00185614: Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Completed
2
63
US
Autologous hematopoietic cell transplant (Auto-HCT), Allogeneic hematopoietic cell transplant (Allo-HCT), Cyclophosphamide, Cytoxan, Neosar, Filgrastim, Neupogen, Granulocyte-colony stimulating factor (G-CSF), Melphalan, Melphalan hydrochloride, Melphalan HCl, Total body irradiation (TBI), Cyclosporine (CSP), Cyclosporine A, Mycophenolate Mofetil (MMF), CellCept
Wen-Kai Weng
Blood Cancer, Multiple Myeloma
04/09
04/10
NCT00482053: Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Terminated
2
3
US
Autologous hematopoietic stem cell transplantation (auto-HSCT), Autologous peripheral blood progenitor cell (PBPC) transplantation, Allogeneic hematopoietic stem cell transplantation (allo-HSCT), Allogeneic peripheral blood progenitor cell (PBPC) transplantation, Total lymphoid irradiation (TLI), Rituximab, Rituxan, Mabthera, Carmustine, BCNU, BiCNU, Etoposide, Eposin, Etopophos, Vepesid, VP-16, Filgrastim, Granulocyte colony-stimulating factor (G-CSF, GCSF), Colony-stimulating factor 3 (CSF-3), Anti-thymocyte globulin (ATG), Cyclosporine, Cyclosporin, CSP, Mycophenolate mofetil (MMF), CellCept, Cyclophosphamide, Cytoxan, Neosar, Acetaminophen, Tylenol, Diphenhydramine, Benadryl, Hydrocortisone, Cortef, Methylprednisolone, Solu-Medrol
Stanford University
Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL), Malignant Lymphoma, Non-Hodgkin
05/10
05/10
NCT00133991: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

Completed
2
23
US
Filgrastim, Neupogen, G-CSF, Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Cy, CTX, HiCy, Cytarabine, Ara-C, Methotrexate, MTX, Prednisone, Deltasone, Hydrocortisone, Vincristine, Oncovin, Leucovorin, Folinic acid
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Leukemia, Lymphoma
08/11
08/13
AALL07P1, NCT00873093: Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Completed
2
148
US, Canada, RoW
L-asparaginase, ASNase, Colaspase, Crasnitin, Elspar, L-ASP, doxorubicin hydrochloride, ADM, ADR, Adria, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef, vincristine sulfate, liposomal vincristine, Marqibo, vincristine liposomal, vincristine sulfate liposome injection, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, prednisone, DeCortin, Deltra, bortezomib, LDP 341, MLN341, VELCADE, pegaspargase, L-asparaginase with polyethylene glycol, Oncaspar, PEG-ASP, PEG-L-asparaginase, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, etoposide phosphate, ETOP, Etopophos, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, filgrastim, G-CSF, Neupogen, leucovorin calcium, CF, CFR, LV, laboratory biomarker analysis, High Dose MTX
National Cancer Institute (NCI)
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
09/14
09/14
NCT00481832: Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Terminated
2
50
US
Cyclophosphamide, Cytoxan, Neosar, BCNU, BiCNU, Carmustine, Etoposide, Eposin, Etopophos, VP-16, Filgrastim, Granulocyte colony-stimulating factor (G-CSF, GCSF), Colony-stimulating factor (CSF) 3, Antithymocyte globulin, ATG, Cyclosporine, cyclosporin, cyclosporin A, Mycophenolate mofetil, MMF, CellCep, Rituximab, Rituxan, MabThera, Autologous hematopoietic stem cell transplantation (auto-HSCT), Autologous peripheral blood progenitor cell (PBPC) transplantation, Allogeneic hematopoietic stem cell transplantation (allo-HSCT), Allogeneic peripheral blood progenitor cell (PBPC) transplantation, Total lymphoid irradiation, TLI, CD34+ Cells, Solu-Medrol, Methylprednisolone
Stanford University
Lymphoma, Non-Hodgkin
10/14
03/17
NCT00354107: Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma

Terminated
1/2
5
US
monoclonal antibody SGN-30, SGN-30, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, etoposide, EPEG, VP-16, VP-16-213, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, pharmacological study, pharmacological studies, laboratory biomarker analysis
National Cancer Institute (NCI)
Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma
01/10
01/10
NCT00626626: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

Terminated
1/2
8
US
Clofar, Cyclophos, Alemtuzumab, CLOLAR, Clofar, Cyclophos,Alemtuzumab(Ph II), Clolar, Campath
Milton S. Hershey Medical Center
Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma
01/10
01/10

Download Options